DSGN · Design Therapeutics, Inc.

$11.87 -0.01 (-0.08%) At close · Jul 28

Market Cap

$741.36M

62.46M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pratik Shah	CEO	$395,000	$144,000	—	$2,754,300	$237,000	$14,000	$3,544,300
Chris M. Storgard	Chief Medical Officer	$339,310	$144,726	—	$1,396,960	$135,724	$14,000	$2,030,270
Sean Jeffries	COO	$484,000	$6,400	—	$1,193,530	$193,600	$14,000	$1,891,530

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean Jeffries	COO	$432,650	$26,940	—	$668,500	$173,060	$13,852	$1,315,002
Pratik Shah	CEO	$395,000	$144,000	—	—	$237,000	$13,800	$789,800
Jae B. Kim	Chief Medical Officer	$362,701	—	—	$334,250	—	$13,700	$710,651

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pratik Shah	CEO	$360,600	$181,552	—	$5,613,680	$148,748	$13,200	$6,317,780
Sean Jeffries	COO	$416,010	—	—	$729,602	$124,803	$13,200	$1,283,615

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pratik Shah	CEO	$337,510	$119,995	—	$3,877,105	$168,755	$12,200	$4,515,565
Sean Jeffries	COO	$400,000	—	—	$2,856,814	$160,010	$12,200	$3,429,024

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pratik Shah	Chief Executive Officer	$310,030	$119,985	—	—	$155,015	—	$585,030
Sean Jeffries	COO	$340,000	—	—	—	$136,000	—	$476,000

Executive changes

Person	Role	Change	Effective	Filed
David Shapiro, M.D.	Class III director	Appointed	2026-03-31	2026-04-01

Key facts CIK 1807120 CUSIP 25056L103 13F (30d) 17 filings 17 filers Visit website Investor relations